face in Medical Technology

Heaviest Smokers Face Greatest Risk of Death After Lung Cancer Diagnosis

MORGANTOWN, W.Va., June 5 /PRNewswire-USNewswire/ -- It's common knowledge that smoking raises risks of lung cancer. And yet researchers haven't known whether continued smoking by lung cancer patients would increase the risk of the cancer's spread. Researchers at West Virginia Univers...

Leader in Prostate Health Urges Prostate Cancer Screening in Face of Contradicting Data

DENVER, March 18 /PRNewswire-USNewswire/ -- New data evaluating the impact of screening on mortality provides mixed messages on the value of prostate cancer screening. The Prostate Conditions Education Council (PCEC), a national organization committed to men's health and a leader in prostate canc...

Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant

Surgery Largest, Most Complex of Its Kind; 80 Percent of Trauma Patient's Face Transplanted CLEVELAND, Dec. 17 /PRNewswire/ -- A multi-disciplinary team of doctors and surgeons at Cleveland Clinic recently performed the first near-total face transplant in the United States. In ...

Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks

MORGANTOWN, W.Va., Sept. 5 /PRNewswire-USNewswire/ -- A team of researchers at West Virginia University has shown that U.S. immigrants from India and Pakistan take on the habits of their adopted country, increasing their risks of prostate cancer among male immigrants and breast cancer among fe...

Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies

- Study Subjects Now In Follow-up Period - EXTON, Pa., Jan. 15 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (Amex: ILE) announced today that injections have been completed in the pivotal Phase III multi-center, double-blind, randomized, placebo-controlled clinical trials evaluat...

Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests

ARLINGTON HEIGHTS, Ill., Oct. 10 /PRNewswire-USNewswire/ -- Face transplants, once on the fringe of medicine, may eventually become more mainstream because of new estimates that suggest the risk of tissue rejection might be lower than previously thought, according to a recent review in Plastic...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

...scovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, s...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

...scovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, s...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

... may lead to infertility. Endometriosis is commonly diagnosed through laparoscopic procedures that are painful and invasive. Additionally, women often face an unusually long delay from the onset of their symptoms to diagnosis, with an average delay of ten years. This partnership will support an ex...

Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture

... by Unilever, is the No. 1 personal wash brand nationwide. One in every three households uses a Dove product, which includes beauty bars, body washes, face care, anti-perspirant/deodorants, body mists, hair care and styling aids. Dove is available nationwide in food, drug and mass outlet stores. ...

July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bell's Palsy and Heart Valve Repair

...ell's palsy -- which causes sudden weakness or paralysis on one half of the face -- is not associated with stroke, and most people recover completely. But a... Symptoms include: Abrupt weakness or limpness on one side of the face (Most people don't experience total paralysis.) A dry, irritated eye ...

Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results

...imitation, that Cardica's current and any future products may never gain any significant degree of market acceptance, that any future Cardica products face regulatory, reimbursement and manufacturing risks, that Cardica's intellectual property rights may not provide adequate protection and that Cardica wi...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...ge Commission. In addition, while the Company has completed delivery of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to FDA's approval of the Company's Biologics License Application for ABthrax. If the Company is unable to meet requirements associated w...

AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine

...quire the use of an adjuvant, and they raise not only strong antibody responses but robust cellular responses, both of which could be important in the face of a developing pandemic where there are several variant virus forms circulating," said Jonathan Smith, AlphaVax's Chief Scientific Officer. ...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

...early detection from the Alzheimer's Disease Neuroimaging Initiative (ADNI), and also survey results from doctors about the enablers and barriers they face in diagnosing people with Alzheimer's. DHA (docosahexaenoic acid) is naturally found in the body in small amounts, and is the most abundant o...

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

...scovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, s...

FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight

...ge Commission. In addition, while the Company has completed shipment of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to FDA's approval of the Company's Biologics License Application for ABthrax. If the Company is unable to meet requirements associated w...

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

...r seizures. Allergic reactions during or after the infusion - hives, difficulty breathing, chest pain, high or low blood pressure, swelling of face and hands, and fever or chills. Lupus-like syndrome - chest discomfort or pain that does not go away, shortness of breath, joint pain, rash on...

Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week

...o moderate ulcerative colitis (UC). Safety and effectiveness of Lialda beyond eight weeks have not been established. "Patients who have UC often face adherence challenges, and persistency is an important consideration in disease management," said Sunanda Kane, MD, MSPH, AGAF, Associate Professor of ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

...usea and fatigue (42% each); periorbital, peripheral and eye edema (33% each); diarrhea, vomiting, rash, lacrimation increased, and anemia (25% each); face edema, pyrexia, exertional dyspnea, rhinitis, and anorexia (17% each). The majority of patients who received Gleevec in the GIST study experience...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

...h a laser-like focus on research that has enormous potential to help patients and save lives. The Stand Up To Cancer model could very well change the face of cancer." Five SU2C Dream Team Grants Each Dream Team's project, funded for three years pending satisfactory achievement of stat...

Getting More From Whole-Transcript Microarrays

...se through Discovery'. Its world-renowned research teams have been responsible for breakthrough science and pioneering therapies that have changed the face of disease and human health worldwide. Today they are focused on four big global medical challenges: cancer, immunity, autoimmunity and infectious dis...

Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)

...change Commission. In addition, while the Company has begun shipment of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to FDA's approval of the Company's Biologics License Application for ABthrax. If the Company is unable to meet requirements associated w...

Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles

...strating that a single treatment with the high frequency radiowave device can safely and effectively tighten and improve the appearance of skin on the face through six months. "Today's FDA clearance of the Pelleve system represents a very exciting step in the introduction of next-generation high freq...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

...ts company, to offer patients a syringe and packaging components that take into account some of the challenges many rheumatoid arthritis (RA) patients face when self-administrating their medicine. UCB's Cimzia(R) (certolizumab pegol) was approved this week by the U.S. Food and Drug Administration (FDA) ...

MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants

...nderstood because these babies often appear as healthy as full-term infants. This study contributes to the growing evidence that, late-preterm infants face greater morbidity and healthcare costs up to at least one year after birth," noted Parthiv Mahadevia, M.D., senior director, health outcomes and phar...

New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus

...lity like that of Bacillus coagulans to survive the challenges probiotics face in reaching the intestinal tract where they can do good" and added that "on...aps provide millions of people with a way to boost the immune system in the face of global health concerns such as flu pandemics." About Ganeden Biote...

Insurance Industry Teleconference on Swine Flu Pandemic Set for May 13

...for alarm, and the industry must prepare and adapt to contain losses in the face of this and other pandemics." Nelson said the objective of the progra...sks and addressing both their immediate and strategic business needs in the face of pandemics. Interviewed for A.M. Best's "BestDay" podcast, Nelson sa...

EPSScentral Responds to Pandemic Alert

...re/ -- EPSScentral LLC today announced its readiness to assist organizations in assembling, communicating, and implementing mitigation measures in the face of WHO's phase 5 classification of the Influenza A crisis. According to the WHO, phase 5 "... is a strong signal that a pandemic is imminent and that...

Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis

...aq: GPRO ) investigational test for the highly specific prostate cancer gene PCA3 may help address some of the well-known challenges that urologists face when diagnosing prostate cancer, such as accurately identifying potentially aggressive cancers while minimizing "false positive" results that can lead...

Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests

...ect our ability to achieve results described in any forward-looking statements. For additional information about risks and uncertainties the companies face and a discussion of financial statements and footnotes, for Gen-Probe, see documents filed with the SEC, including Gen-Probe's most recent annual repo...

Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C

...change Commission. In addition, while the Company has begun shipment of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to acceptance of future shipments and FDA's approval of the Company's Biologics License Application for ABthrax, if and when it is submi...

B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase

...rward to the opportunity to interact with other healthcare professionals and demonstrate our solutions in the kind of clinical scenarios our customers face every day," said Zaffrin. B. Braun Infusion Pumps deliver critical IV medications to patients and communicate infusion data to the company's Do...

Research Shows VASER(R) Lipo Results in Excellent Skin Tightening

...ults. The VASER Lipo System was designed to provide physicians with a versatile tool to treat all areas of the body, from small procedures in the face and neck, to large volume treatments in the abdomen and back. VASER ultrasonic energy is able to selectively liquefy fat while preserving important ti...

March 2009 Mayo Clinic Health Letter Highlights Knee Repair Surgery, Anxiety Disorder and Preventing Blood Clots

.... With generalized anxiety disorder, shedding worries is difficult, even when the worry is seemingly out of proportion to the concern. ("I can't face my book club tonight." "I wish I didn't have to leave the house and deal with anyone." "I hope I don't feel sick again today. What if I am?") Ot...

Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C

...change Commission. In addition, while the Company has begun shipment of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to acceptance of future shipments and FDA's approval of the Company's Biologics License Application for ABthrax, if and when it is submi...

New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation

... over 75% improvement. Why It Works The DOT procedure ( www.dottherapy.com ) precisely delivers CO2 laser energy to targeted areas on the face or non-facial areas like the neck and decolletage, and effectively treats sun damage, wrinkles, fine lines, and acne scarring. Unlike any other skin r...

Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant

...ate the efficacy of three treatments of Isolagen Therapy on one side of the face as compared with placebo treatment on the other side of the face for the treatment of moderate to severe acne scars. The primary efficacy en...

Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

...change Commission. In addition, while the Company has begun shipment of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to acceptance of future shipments and FDA's approval of the Company's Biologics License Application for ABthrax, if and when it is submi...

Scientists Discover Why Teeth Form in a Single Row

...s the process by which information stored in genes is converted into proteins that make up the body's structures and carry its messages. As the baby's face takes shape in the womb, the development of teeth and palate are tightly controlled in space and time by gene expression. Related abnormalities result...